Prescription drug · ANDA
Etomidate NDC 51662-1542
Etomidate 40 mg/20mL · Injection, Solution · Intravenous · HF Acquisition Co LLC, DBA HealthFirst
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51662-1542-1 | 5166215420151662154201 | 20 mL in 1 VIAL, SINGLE-DOSE (51662-1542-1)Marketed from Apr 9, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Etomidate
- Generic name (nonproprietary)
- etomidate
- Active ingredients
- Etomidate — 40 mg/20mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 206126
- Marketing start
- Listing expires
- Other FDA classes
- General Anesthesia (Physiologic effect)
- Identifiers
- Product ID 51662-1542_dc43b289-4f33-1c1e-e053-2995a90a3a23SPL ID dc43b289-4f33-1c1e-e053-2995a90a3a23SPL set ID dc43b289-4f32-1c1e-e053-2995a90a3a23RxCUI 1654008UNII Z22628B598
- Pharmacologic class
- General Anesthetic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N451662154201followed by a unit qualifier and the quantityPackage 51662-1542-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS & USAGE Etomidate Injection is indicated by intravenous injection for the induction of general anesthesia. When considering use of Etomidate Injection, the usefulness of its hemodynamic properties (see CLINICAL PHARMACOLOGY ) should be weighed against the high frequency of transient skeletal muscle movements (see ADVERSE REACTIONS ). Intravenous Etomidate Injection is also indicated for the supplementation of subpotent anesthetic agents, such as nitrous oxide in oxygen, during maintenance of anesthesia for short operative procedures such as dilation and curettage or cervical conization.
Excerpt only. Read the full label for complete information.
About NDC 51662-1542
- What is NDC 51662-1542?
- 51662-1542 is the product NDC for Etomidate, Etomidate 40 mg/20mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Etomidate.
- What is the active ingredient?
- Etomidate.
- Who is the labeler?
- HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Etomidate?
- 21 other product NDCs are listed under this name. See all Etomidate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Etomidate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Etomidate | Etomidate 2 mg/mL | Injection, SolutionIntravenous | Caplin Steriles Limited | 65145-127 | 65145-0127-10 |
| Etomidate | Etomidate 2 mg/mL | Injection, SolutionIntravenous | Caplin Steriles Limited | 65145-128 | 65145-0128-10 |
| Etomidate | Etomidate 2 mg/mL | Injection, SolutionIntravenous | Armas Pharmaceuticals Inc. | 72485-508 | 72485-0508-10 |
| Etomidate | Etomidate 2 mg/mL | Injection, SolutionIntravenous | Armas Pharmaceuticals Inc. | 72485-509 | 72485-0509-10 |
| Etomidate | Etomidate 2 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-445 | 65219-0445-22 |
| Etomidate | Etomidate 2 mg/mL | InjectionIntravenous | Civica, Inc. | 72572-160 | 72572-0160-10 |
| Etomidate | Etomidate 2 mg/mL | InjectionIntravenous | Civica, Inc. | 72572-161 | 72572-0161-10 |
| Etomidate | Etomidate 2 mg/mL | Injection, SolutionIntravenous | Fresenius Kabi USA, LLC | 65219-447 | 65219-0447-20 |
| Etomidate | Etomidate 2 mg/mL | InjectionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1485 | 51662-1485-01 |
| Etomidateetomidate injection | Etomidate 2 mg/mL | SolutionIntravenous | Fosun Pharma USA Inc | 72266-146 | 72266-0146-10 |
Other NDCs under ANDA 206126
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Etomidate | Etomidate 20 mg/10mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-221 |
| Etomidate | Etomidate 40 mg/20mL | Injection, SolutionIntravenous | Eugia US LLC | 55150-222 |
| ETOMIDATE injection, solution | Etomidate 20 mg/10mL | Injection, SolutionIntravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1634 |